BioMerieux (FRA:EYWN) Cash Flow for Dividends : €-100 Mil (TTM As of Jun. 2024)

View and export this data going back to 2004. Start your Free Trial

What is BioMerieux Cash Flow for Dividends?

BioMerieux's cash flow for dividends for the six months ended in Jun. 2024 was €-100 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jun. 2024 was €-100 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

BioMerieux's quarterly payment of dividends declined from Jun. 2023 (€-100 Mil) to Dec. 2023 (€0 Mil) but then increased from Dec. 2023 (€0 Mil) to Jun. 2024 (€-100 Mil).

BioMerieux's annual payment of dividends increased from Dec. 2021 (€-73 Mil) to Dec. 2022 (€-101 Mil) but then declined from Dec. 2022 (€-101 Mil) to Dec. 2023 (€-100 Mil).

BioMerieux Cash Flow for Dividends Historical Data

The historical data trend for BioMerieux's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMerieux Cash Flow for Dividends Chart

BioMerieux Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-41.30

-22.50

-73.10

-101.20

-100.20

BioMerieux Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Cash Flow for Dividends	Get a 7-Day Free Trial															-101.20	-	-100.20	-	-100.20

BioMerieux Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-100 Mil.

BioMerieux Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of BioMerieux's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

BioMerieux Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (FRA:EYWN) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

BMXMF:USA BIMp:UK 0RUG:UK BIM:France

Address

Marcy l’Etoile, Lyon, FRA, 69280

Website

http://www.biomerieux.com

BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (34% of 2023 sales), microbiology (39%), immunoassays (10%), and industrial applications (about 17%). The Amercas account for the largest portion of the firm's revenue (45%), followed by Europe, the Middle East, and Africa (31%), and Asia-Pacific (16%). BioMérieux is headquartered in Marcy-l'Etoile, France.

BioMerieux Headlines

No Headlines